Tag Archives: collaborative practice agreement
Under a new statewide protocol based on Senate Bill 16-135, only Colorado-licensed pharmacists that have completed an Accreditation Council for Pharmacy Education (ACPE) accredited educational training program related to the prescribing of contraceptives by a pharmacist, may dispense hormonal contraceptive patches and oral hormone contraceptives to patients who are at least 18 years of age.
Additionally, for new patients requesting contraceptive services, a participating pharmacist must:
- Obtain a completed Colorado Self-Screening Risk Assessment Questionnaire;
- Utilize and follow the Colorado Standard Procedures Algorithm to perform the patient assessment;
- Prescribe, if clinically appropriate, the hormonal contraceptive patch or self-administered oral hormonal contraceptive, or refer to a healthcare practitioner;
- Provide the patient with a Visit Summary;
- Advise the patient to consult with a primary care practitioner or women’s health care practitioner;
- Refer any patient that may be subject to abuse to an appropriate social services agency; and
- Ensure that the pharmacy provides appropriate space to prevent the spread of infection and ensure confidentiality.
Colorado Board of Pharmacy Approved Protocols include:
Hormonal Contraception Protocol A (includes Standard Procedures Algorithm and the Self-Screening Risk Assessment Questionnaire)
Smoking Cessation: currently being addressed the Colorado Board of Pharmacy (watch for updates)
With the passage of Colorado SB 16-135, which allows the Boards of Pharmacy, Nursing, and Medicine to collaborate on statewide protocols to address public health needs and improve patient outcomes, Colorado becomes the third state to authorize pharmacists to prescribe oral contraception.
Once trained, qualified pharmacists will screen all patients seeking pharmacist-prescribed contraception for potential contraindications and underlying health conditions in order to determine the most appropriate contraception for each individual patient.
Colorado is also considering a similar collaborative statewide protocol that would authorize pharmacists to furnish smoking cessation medications.
Ohio House Bill 188 (HB 188), which passed last year, greatly expands the role of the Ohio pharmacist by streamlining the collaborative practice agreement paperwork and allowing physicians to enter into an agreement with multiple pharmacists to manage drug therapy for their patients.
Under an Ohio collaborative practice agreement, pharmacists can order blood or urine tests, analyze the results and then, add, modify or discontinue a drug without requiring a qualified physician to cosign, provided the pharmacist’s work is done within the scope of the collaborative practice agreement.
Additionally, HB 188 allows pharmacists to order a 30-day supply of a prescription refill for patient if the prescription has expired and a physician cannot be reached.
With the passage of HB 188, Ohio joins other states such as California, North Carolina, Oregon and Washington, that have recently updated their collaborative practice agreements. Ultimately, the goal is to have pharmacists become more involved in nondispensing, hands-on patient care.